National Bank of Canada
NGNE icon

National Bank of Canada’s Neurogene NGNE Stock Holding History

National Bank of Canada’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161 Hold
8
– – ﹤0.01% 2808
2025
Q4 		$164 Hold
8
– – ﹤0.01% 2760
2025
Q3 		$139 Hold
8
– – ﹤0.01% 2756
2025
Q2 		$119 Hold
8
– – ﹤0.01% 2853
2025
Q1 		$94 Buy
+8
New +$139 ﹤0.01% 2718
2024
Q4 		– Sell
-9
Closed -$378 – 3118
2024
Q3 		$378 Buy
9
+1
+13% +$39 ﹤0.01% 2497
2024
Q2 		$323 Hold
8
– – ﹤0.01% 2585
2024
Q1 		$258 Hold
8
– – ﹤0.01% 2627
2023
Q4 		$158 Sell
8
-1
-11% -$14 ﹤0.01% 2644
2023
Q3 		$134 Hold
9
– – ﹤0.01% 2714
2023
Q2 		$144 Buy
+9
New +$148 ﹤0.01% 2677

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

National Bank of Canada's NGNE Position: Q1 2026 in Review

National Bank of Canada held its Neurogene (NGNE) position steady in Q1 2026 at 8 shares worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #2808.

National Bank of Canada first reported a position in NGNE in Q2 2023 and has held it in 11 quarters since. The position peaked at $378 in Q3 2024. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • National Bank of Canada held 8 shares of Neurogene worth $161 as of Q1 2026.
  • National Bank of Canada left its Neurogene share count unchanged in Q1 2026.
  • Neurogene made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2808 holding.
  • National Bank of Canada first reported a position in Neurogene in Q2 2023 and has held it in 11 quarters since.
  • National Bank of Canada's Neurogene position peaked at $378 in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.